MyChelle Dermaceuticals, LLC

MyChelle Dermaceuticals is a skincare company specializing in premium, eco-friendly products that prioritize clean formulations and cater to various skin concerns. Their offerings include cleansers, serums, and sun care solutions. Founded in 2000, MyChelle Dermaceuticals focuses on creating effective skincare solutions. The company underwent a change in ownership in December 2017 when it was acquired by French Transit, Ltd.

, a portfolio company of Juggernaut Capital Partners, from Encore Consumer Capital. The company is headquartered in Louisville, US. MyCHELLE Dermaceuticals specializes in premium natural skincare products that focus on clean, eco-friendly formulations. The company's core offerings include a variety of skincare solutions such as cleansers, moisturizers, serums, exfoliators, and sun care products, all designed to address specific skin concerns including aging, hydration, and environmental protection.

MyCHELLE emphasizes transparency in its ingredient sourcing, committing to cruelty-free practices and environmental sustainability, which appeals to health-conscious consumers and individuals seeking effective skincare solutions. The products are primarily targeted at consumers in North America, including the United States and Canada, as well as select international markets. MyCHELLE Dermaceuticals generates revenue through direct-to-consumer sales, primarily facilitated via its e-commerce platform and select retail partnerships. Transactions are structured around one-time purchases of individual products, with pricing reflecting the premium nature of their formulations.

Notable products include the Remarkable Retinal™ Eye Cream and Perfect C™ Serum 17%, which are flagship offerings within their product line. The company’s pricing strategy is positioned to attract both individual consumers and skincare salons or wellness centers that might incorporate these products into their service offerings. Sales growth is supported by ongoing marketing initiatives and customer engagement strategies aimed at promoting product efficacy and brand loyalty. MyChelle Dermaceuticals plans to expand its product line with new launches scheduled for 2024, focusing on innovative formulations targeting specific skin concerns.

The company aims to enter additional international markets, particularly throughout Europe and Asia, by the end of 2025. Recent funding from the December 2017 acquisition will be utilized to support these initiatives, enhancing product development and expanding market reach.